25.16 USD
▼-0.13-0.53%
盘后 25.07 -0.35%
2026-09-16
市值
—
规模 AUM
$5.81M
EPS
—
股息率
—
52 周区间
22.63 – 27.94
成交量
204.00
Beta
0.40
目标价
—
52W 低 22.6352W 高 27.94
价格走势
公司简介
The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.